Hemophilia is a genetic disorder impairing blood clotting, leading to excessive bleeding. It includes types A, B, C, and acquired forms, each caused by specific factor deficiencies. Treatment involves factor replacement and innovative options like gene therapy. Early diagnosis is vital for preventing complications and improving life quality.

Hemophilia is a hereditary bleeding disorder where the body's ability to form blood clots is impaired due to a lack of specific clotting proteins. This leads to abnormal bleeding episodes that can be both external and internal, increasing the risk of complications. Affected individuals may suffer from joint swelling, unexplained bruises, prolonged bleeding following injuries, and rare cases of brain hemorrhages. The main types include Hemophilia A, B, C, and acquired forms, each linked to specific clotting factor deficiencies. Management typically involves replacing missing factors with plasma-derived or synthetic products, and new methods like gene therapy are emerging. Early detection and treatment are crucial for preventing serious health consequences and maintaining a better quality of life.